Phase 1 Hypersensitivity Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Novel Biomarkers of Non-IgE Immediate Hypersensitivity Drug Reactions

Healthy VolunteerVancomycinHypersensitivity Reactions

Johns Hopkins University25 enrolled1 locationNCT07605806

Recruiting

Phase 1

Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing, Immunotherapy or Oral Challenges

AnaphylaxisHypersensitivity

Dr. George Luciuk100 enrolled1 locationNCT07038746